Factors associated with long-term damage in the ANCA-associated vasculitides: An analysis of cohorts from the European vasculitis study group (EUVAS) therapeutic trials

Factors associated with long-term damage in the ANCA-associated vasculitides: An analysis of cohorts from the European vasculitis study group (EUVAS) therapeutic trials

Bibliographic Details
Main Authors:	Robson, J, Doll, H, Oliver, F, Ravi, S, Lorraine, H, Peter, H, David, J, Chetan, M, Kerstin, W, Raashid, L
Format:	Journal article
Published:	2013

Similar Items

Treatment related damage in the ANCA-associated vasculitides: An analysis of cohorts from the European Vasculitis Study Group (EUVAS) therapeutic trials
by: Robson, J, et al.
Published: (2013)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
by: Robson, J, et al.
Published: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
by: Robson, J, et al.
Published: (2015)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

Ongoing european research initiatives in systemic vasculitides: The EUVAS program
by: Luqmani, R, et al.
Published: (2005)

Classification criteria for the anca-associated vasculitides
by: Robson, J, et al.
Published: (2019)

ANCA-associated vasculitides in childhood
by: Szabó András, et al.
Published: (2011-09-01)

Atherosclerosis in ANCA-associated systemic vasculitides
by: E I Kuznetsova, et al.
Published: (2012-06-01)

Towards diagnostic criteria for the ANCA-associated vasculitides.
by: Luqmani, R
Published: (2007)

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
by: Robson, J, et al.
Published: (2014)

French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
by: Benjamin Terrier, et al.
Published: (2020-12-01)

THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
by: Yew, S, et al.
Published: (2012)

Damage assessment in ANCA-associated vasculitis.
by: Bhamra, K, et al.
Published: (2012)

The role of rituximab in the treatment of ANCA-associated vasculitides (AAV)
by: Thomas Daikeler, et al.
Published: (2015-01-01)

Outcome measures in ANCA-associated vasculitis.
by: Suppiah, R, et al.
Published: (2010)

Correction to: French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)
by: Benjamin Terrier, et al.
Published: (2021-04-01)

Upper respiratory tract manifestations in patients with ANCA-associated vasculitides and their association with the presence and type of ANCA
by: I. G. Smirnova, et al.
Published: (2021-10-01)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
by: Robson, J, et al.
Published: (2013)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
by: Suppiah, R, et al.
Published: (2011)

International guidelines for the management ofANCA-associated systemic vasculitides
by: T. V. Beketova
Published: (2019-03-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]
by: Austin K, et al.
Published: (2022-10-01)

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides
by: N M Bulanov, et al.
Published: (2018-06-01)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
by: Yew, S, et al.
Published: (2012)

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Updates in ANCA-associated vasculitis
by: Carolyn Ross, et al.
Published: (2022-07-01)

Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01)

ANCA Associated Vasculitis Subtypes: Recent Insights and Future Perspectives
by: Austin K, et al.
Published: (2022-04-01)

A rare case of spontaneous renal rupture caused by ANCA - associated vasculitides
by: Yongquan Yu, et al.

Vasculites associadas ao anticorpo anticitoplasma de neutrófilo (Anca) Vasculitides associated to antineutrophil cytoplasmic antibodies (Anca)
by: Boris A. Cruz
Published: (2007-04-01)

Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire
by: Robson, J, et al.
Published: (2018)

Diagnosis and management of ANCA associated vasculitis.
by: Berden, A, et al.
Published: (2012)

Explaining fatigue in ANCA-associated vasculitis
by: Basu, N, et al.
Published: (2013)

Explaining fatigue in ANCA-associated vasculitis.
by: Basu, N, et al.
Published: (2013)

Cutaneous manifestations of ANCA-associated vasculitis
by: Chiesafuxench, Z, et al.
Published: (2016)

Cardiovascular outcomes in ANCA associated vasculitis
by: Mukhtyar, C, et al.
Published: (2008)

Granulomatous Inflammation in ANCA-Associated Vasculitis
by: Antje Müller, et al.
Published: (2021-06-01)

The involvement of NETs in ANCA-associated vasculitis
by: Satoka Shiratori-Aso, et al.
Published: (2023-09-01)